Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Best Medications for Headache When NSAIDs Are Ineffective

Treatment Algorithm Based on Headache Type and Severity

  • For patients with migraine headaches that do not respond to NSAIDs, the American College of Physicians recommends a triptan (such as sumatriptan) combined with acetaminophen as the first-line treatment 1
  • The choice of specific triptan should be based on route of administration and cost, according to the American College of Physicians 1
  • Treatment with triptans should begin as soon as possible after headache onset for improved efficacy, as recommended by the American College of Physicians 1
  • For moderate to severe acute episodic migraine, the American Headache Society recommends CGRP antagonists (gepants) such as rimegepant, ubrogepant, or zavegepant 1, 2

Specific Medication Evidence and Considerations

  • Subcutaneous and intranasal sumatriptan are particularly useful for patients with nausea and vomiting, according to the American Academy of Neurology 3
  • Triptans are contraindicated in patients with uncontrolled hypertension, coronary artery disease, and basilar or hemiplegic migraine, as stated by the American Heart Association 5

Other Options

  • Dihydroergotamine nasal spray has good evidence for efficacy and safety for acute migraine attacks, according to the American Academy of Neurology 2, 4
  • Antiemetics like metoclopramide or prochlorperazine can be effective both for nausea and as primary headache treatment, as recommended by the American Gastroenterological Association 3

Important Cautions

  • The American College of Physicians recommends avoiding opioids and butalbital-containing medications for routine headache treatment due to the risk of dependency, rebound headaches, and eventual loss of efficacy 1, 2
  • Medication overuse headache can occur with frequent use of acute medications, defined as ≥15 days per month with most medications or ≥10 days per month with triptans, according to the American Headache Society 1, 2
  • If episodic migraine occurs frequently or treatment doesn't provide adequate response, the American Academy of Neurology recommends considering preventive medications 1
  • Patients who don't respond to one triptan may respond to another within the same drug class, as stated by the American College of Physicians 1

Special Populations

  • For pregnant or breastfeeding patients, the American College of Obstetricians and Gynecologists recommends discussing the adverse effects of pharmacologic treatments during pregnancy and lactation 1

REFERENCES

2

Alternative Treatment Options for Migraine Relief [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Acute Headache Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Migraine Treatment Options Without Opiates or Diphenhydramine [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025